Personal Track Record
This is not an investment model
- It is a record of a member’s personal broker account as reported to Covestor
- It cannot be mirrored
Feb 25, 2010
biomedinvest - View Profile
Personal Track Record
| Inception date | February 18, 2010 |
| Long/Short | Long and Short |
| Cap bias | Small cap |
| Holding Period | Short term |
Performance and Risk
Performance Summary (as at end of February 09, 2012)
| Inception February 18, 2010 | Member | S&P 500 |
|---|---|---|
| Month to date (%) | 10.59 | 4.41 |
| 3 month (%) | 10.30 | 4.76 |
| 1 year (%) | 9.05 | 2.09 |
| Annualized since inception (%) | 1.33 | 0.68 |
| Since inception (%) | 2.62 | n/a |
| Sharpe (annualized) | 0.05 | 0.01 |
| % of positive months | 50.00 | 60.81 |
Past performance is not indicative of future performance
Commentary - Latest Posts
-
Thoratec - THOR March 16, 2010
Consensus much too bullish on THOR (extract of Lazard and WF analyst reports)
THOR can probably meet its guidance for the next two quarters, but we believe it's longer term outlook is far too optimistic, given the increasing competition emerging (HTWR). Lazard target $23. WF Securities target $30 (Once HeartMate II receives approval for destination therapy, attention will shift to the uptake of HeartMate II which we think will fall short of expectations. The next catalyst......
-
Xenoport XNPT February 18, 2010
Good platform with multiple product opportunities
4 ongoing Phase II trials, 1 Phase I
200 M mkt cap
150 M cash$50 M enterprise value: that's cheaper than 8 years ago
66% devaluation due to a dissapointing FDA decision on one of three productsThe markets overreacted.
Bought at $6.6 Target: $12
- Job Title Managing Partner
- Industry Investment Management
- Expertise 10-20 years
- Education Ph.D. Biochemistry - Vienna; MBA - Rutgers
- Qualifications PH.D., MBA
- Year of Birth 1960
- Country United States
- State California
Follow investment models for free
Start FREE Trial - Create Mirroring AccountImportant Information
- Past performance is no guarantee of future results.
- Performance of a Personal Track Record is calculated by Covestor on a daily time-weighted basis of equity positions in the account provided by the member. It is exclusive of any commissions, fees, dividends, earnings distributions, and cash in the portfolio.
- Month to Date returns and Since Inception returns are revised daily. All other returns (month, 3 month, year to date, et al) are calculated as of the most recent month end date.
- All graph data is as of the end of day for the referenced period, unless otherwise specified.
- Benchmark returns have been calculated by Covestor using a time-weighted calculation of daily index valuations and do not include cash, dividends and earnings distributions, or transaction costs. More
- All Personal Track Record information including personal data, profiles, strategies, commentary, and historical results outside of Covestor has been provided by the Member. Covestor makes no representation or warranty of its accuracy, completeness or relevance and it does not represent the opinions of Covestor.